Voyager Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	43.31	65.3	71.37	68.8	98.96	117.43
Short-Term Investments	98.17	131.15	195.32	162.07	19.89	15.11
Cash & Short-Term Investments	141.48	196.45	266.68	230.88	118.85	132.54
Cash Growth	-40.06%	-26.34%	15.51%	94.26%	-10.33%	-26.83%
Accounts Receivable	1.65	1.91	2.18	83.49	0.26	0.73
Other Current Assets	3.86	4.33	7.95	5.32	5.39	3.43
Total Current Assets	146.98	202.69	276.81	319.68	124.5	136.7
Net Property, Plant & Equipment	39.43	41.61	47.66	30	33.34	55.38
Long-Term Investments	30.18	5.24	65.7	-	-	-
Other Long-Term Assets	2.74	2.74	2.87	1.59	1.52	1.78
Total Assets	219.33	252.28	393.05	351.28	159.36	193.86
Accounts Payable	2.72	5.01	4	1.6	2.57	0.57
Accrued Expenses	6.97	12.1	14.17	16.82	7.82	10.95
Current Portion of Leases	7.36	7.84	7.23	3.2	-	-
Unearned Revenue	0.4	1.59	24.39	42.88	59.38	33.89
Other Current Liabilities	-	-	-	-	2.83	5.57
Total Current Liabilities	17.45	26.54	49.79	64.51	72.59	50.98
Long-Term Leases	27.2	28.66	36.5	17.09	-	-
Other Long-Term Liabilities	1	1	7	33.36	27.75	47.82
Total Long-Term Liabilities	28.2	29.66	43.5	50.45	27.75	47.82
Total Liabilities	45.66	56.2	93.29	114.96	100.34	98.8
Common Stock	0.06	0.06	0.06	0.04	0.04	0.04
Additional Paid-in Capital	647.71	641.9	626.3	497.51	452.71	442.26
Accumulated Other Comprehensive Income	-0.26	0.03	-0.41	-0.05	-0.22	-0.14
Retained Earnings	-473.84	-445.91	-326.18	-261.18	-393.51	-347.1
Shareholders' Equity	173.67	196.08	299.76	236.32	59.02	95.06
Total Liabilities & Equity	219.33	252.28	393.05	351.28	159.36	193.86
Total Debt	34.57	36.5	43.73	20.29	0	0
Net Cash (Debt)	106.91	159.95	222.96	210.58	118.85	132.54
Net Cash Growth	-33.16%	-28.26%	5.88%	77.19%	-10.33%	-26.83%
Net Cash Per Share	1.81	2.72	3.87	4.72	3.10	3.52
Book Value	173.67	196.08	299.76	236.32	59.02	95.06
Book Value Per Share	2.94	3.33	5.20	5.30	1.54	2.52
Tangible Book Value	173.67	196.08	299.76	236.32	59.02	95.06
Tangible Book Value Per Share	2.94	3.33	5.20	5.30	1.54	2.52

SEC Filings: 10-K · 10-Q